According to a new report from Intel Market Research, the global Continuous Glucose Monitoring (CGM) Devices market was valued at USD 6.53 billion in 2025 and is projected to reach USD 15.87 billion by 2034, growing at a robust CAGR of 10.2 % during the forecast period (2026–2034). This growth is propelled by the expanding global diabetes burden, rapid technological innovations in sensor...
Diabetes testing systems are foundational to effective disease management, enabling timely diagnosis, continuous glucose tracking, and informed therapeutic decision-making. Their importance within the healthcare and life sciences ecosystem continues to grow as healthcare systems worldwide shift toward preventive care, patient-centric monitoring, and data-driven disease management strategies....